Cargando…
Hyperkalemia in Ambulant Postcardiac Surgery Patients during Combined Therapy with Angiotensin-converting Enzyme Inhibitor, Spironolactone, and Diet Rich in Potassium: A Report of Two Cases and Review of Literature
INTRODUCTION: Potassium is the most abundant cation in intracellular compartment. A deficiency or excess of its serum concentration can be deleterious to the one suffering from a cardiac ailment. Post cardiac surgery patients are often on multiple drugs like angiotensin receptor blockers (ARBs), ang...
Autores principales: | Dixit, Aanchal, Majumdar, Gauranga, Tewari, Prabhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489390/ https://www.ncbi.nlm.nih.gov/pubmed/30971598 http://dx.doi.org/10.4103/aca.ACA_65_18 |
Ejemplares similares
-
Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
por: Jun, Hye-Ran, et al.
Publicado: (2021) -
Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020) -
Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease
por: WANG, WEISONG, et al.
Publicado: (2013) -
A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
por: Sadjadi, Seyed Ali, et al.
Publicado: (2009) -
No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)